Biocure Technology Inc. is a listed company. Its insiders report their share dealings to SEDI. The past year has been quiet: not a single insider filing for Biocure Technology Inc. The previous disclosure was published on 7 July 2025.
Looking back to 2017, when coverage begins, insiders filed 1 purchase and 20 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 45 declarations
Biocure Technology Inc. is a company listed on the Toronto Stock Exchange, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the field of medical treatments.